FDA Approves First-in-Class Asundexian for Stroke Prevention
Summary
Asundexian becomes the first FDA-approved factor XIa inhibitor, offering a new option for preventing recurrent ischemic stroke when added to antiplatelet therapy.
Description from Medscape.
Who is covering this
-
FDA Approves First-in-Class Asundexian for Stroke Prevention
Asundexian becomes the first FDA-approved factor XIa inhibitor, offering a new option for preventing recurrent ischemic stroke when added to antiplatelet therapy.
Related stories
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
27 sourcesvia BBC NewsTruth score 9110
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
7 sourcesvia The HinduTruth score 731
FDA scientists opposed Trump administration’s move to ease peptide access
4 sourcesvia The GuardianTruth score 66
Blood pressure medication recalled nationwide
4 sourcesvia USA TODAYTruth score 671
Patanjali ghee among Rs 9 crore food stock seized in Maharashtra FDA crackdown
3 sourcesvia India TodayTruth score 54
Trump administration says biggest changes coming to infant formula in nearly 30 years
2 sourcesvia ABC News (US)Truth score 533
Comments
Comments need JavaScript.